Cargando…
Heparan Sulfate Binding Cationic Peptides Restrict SARS-CoV-2 Entry
A novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global pandemic. While the world is striving for a treatment modality against SARS-CoV-2, our understanding about the virus entry mechanisms may help to design entry inhibitors, which may help to limit the virus spread...
Autores principales: | Suryawanshi, Rahul K., Patil, Chandrashekhar D., Koganti, Raghuram, Singh, Sudhanshu Kumar, Ames, Joshua M., Shukla, Deepak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308704/ https://www.ncbi.nlm.nih.gov/pubmed/34202835 http://dx.doi.org/10.3390/pathogens10070803 |
Ejemplares similares
-
Dysregulation of Cell Signaling by SARS-CoV-2
por: Suryawanshi, Rahul K., et al.
Publicado: (2021) -
Pathophysiology of reinfection by exogenous HSV-1 is driven by heparanase dysfunction
por: Suryawanshi, Rahul K., et al.
Publicado: (2023) -
Novel Heparan Sulfate-Binding Peptides for Blocking Herpesvirus Entry
por: Dogra, Pranay, et al.
Publicado: (2015) -
Heparanase, cell signaling, and viral infections
por: Koganti, Raghuram, et al.
Publicado: (2020) -
Diversity of Heparan Sulfate and HSV Entry: Basic Understanding and Treatment Strategies
por: Tiwari, Vaibhav, et al.
Publicado: (2015)